Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM)

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Conclusion and Future Directions: Intrapleural delivery is an effective way of delivering chemotherapy in patients with MPM. Intrapleural chemotherapy can be particularly effective early, when the disease is limited to the pleural surface. However, the current data with the adjuvant intrapleural chemotherapy is inconclusive and should not be routinely used except in the setting of clinical trials. Our results with intrapleural L-NDDP are very encouraging and warrant further studies either as a neoadjuvant or an adjuvant to debulking surgery or in combination with intravenous chemotherapy.

Original languageEnglish (US)
Title of host publicationMalignant Mesothelioma
Subtitle of host publicationAdvances in Pathogenesis, Diagnosis, and Translational Therapies
PublisherSpringer New York
Pages631-637
Number of pages7
ISBN (Print)0387229493, 9780387229492
DOIs
Publication statusPublished - Dec 1 2005

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Piperdi, B., Shin, D. M., & Perez-Soler, R. (2005). Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM). In Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies (pp. 631-637). Springer New York. https://doi.org/10.1007/0-387-28274-2_42